SCHEMBL360442

SCHEMBL360442

CN1CC[C@H](NC(=O)NCc2cccc(O)c2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR1 P30872 1/20 0.53
SSTR4 P31391 1/20 0.53
DRD4 P21917 1/20 0.50
SIGMAR1 Q99720 1/20 0.46
HPGD P15428 3/20 0.46
EPHX1 P07099 2/20 0.46
CCKBR P32239 1/20 0.46
KDM5A P29375 1/20 0.46
MCHR1 Q99705 3/20 0.44
EPHX2 P34913 2/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
NAMPT P43490 1/20 0.43
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CCR5 P51681 1/20 0.41
MC4R P32245 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL357690 1.00 SSTR1 (0.53) SSTR1SSTR4DRD4SIGMAR1HPGD
SCHEMBL14392388 1.00 SSTR1 (0.53) SSTR1SSTR4DRD4SIGMAR1HPGD
SCHEMBL1908903 0.88 SSTR1 (0.67) SSTR1SSTR4DRD4HPGDEPHX1
SCHEMBL13242298 0.86 DRD4 (0.66) SSTR1SSTR4DRD4HPGDEPHX1
SCHEMBL14263126 0.81 SSTR1 (0.57) SSTR1SSTR4DRD4HPGDEPHX1
SCHEMBL14263134 0.81 DRD4 (0.55) SSTR1SSTR4DRD4HPGDEPHX1
SCHEMBL359497 0.80 ALDH1A1 (0.51) DRD4KMT2ANAMPT
SCHEMBL4981951 0.80 MCHR1 (0.56) SSTR4DRD4SIGMAR1HPGDEPHX1
SCHEMBL4981612 0.80 DRD4 (0.57) DRD4SIGMAR1HPGDEPHX1MCHR1
SCHEMBL1912322 0.79 EPHX2 (0.50) EPHX2MEN1KMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013211-B1 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2012-03-14 EP disclosed